Why Metro Orlando? -

The growing biotechnology and life science industry in Metro Orlando is focused on improving our quality of life through a wide-range of leading edge endeavors in such diverse areas as:

Agritechnology Biomedical engineering Clinical trials Diagnostic testing	Genomics Nutraceuticals Pharmaceuticals
Complemented by nationally-recognized local hospitals and research facilities, along with a wealth of medical equipment vendors, the sector is well structured for continued expansion.

Marketplace: There are 150+ biotechnology and life science companies located in Metro Orlando, generating revenues of $2.6 billion. Areas of concentration include:

Evidenced-based clinical lab testing
Bioterrorism defense
Functional foods
Medical training simulation

Plant pathology
Disease management
Telemedicine services

Workforce: The biotechnology and life science sector in Metro Orlando benefits from a steady flow of graduates from the region’s well-regarded post-secondary institutions and vocational programs. Medical training conducted at the region’s award-winning hospitals further adds to the workforce quality.

Education: Metro Orlando’s location in the center of Florida’s Intelligence Triangle enables the region to draw on the skill and talent of graduates from the state’s six top universities. Local teaching hospitals also offer valuable training courses in a variety of specialties.

Industry Organizations and Involvement: Metro Orlando features support organizations devoted to raising the visibility of the biotechnology and life science industry by providing the resources necessary to contribute to the success of businesses in the sector.

Incentives: The Metro Orlando community is focused on advancing the growth of all sectors of high tech industry in the region. To that end, grant funding and other financial incentives are available to attract new high tech businesses to the area and to enhance existing organizations. As an example of such innovative incentives, UCF and local government created initial stage funding for a biotechnology company by providing funding for a state-of-the-art greenhouse research project.